Sickle Cell Disease Drug Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Sickle Cell Disease Drug in global, including the following market information:
Global Sickle Cell Disease Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sickle Cell Disease Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Sickle Cell Disease Drug companies in 2021 (%)
The global Sickle Cell Disease Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ARQ-092 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sickle Cell Disease Drug include Acceleron Pharma Inc, Addmedica SAS, Angiocrine Bioscience Inc, Annexin Pharmaceuticals AB, ArQule Inc, Bio Products Laboratory Ltd, Bioverativ Inc, bluebird bio Inc and Bristol-Myers Squibb Co, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sickle Cell Disease Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sickle Cell Disease Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sickle Cell Disease Drug Market Segment Percentages, by Type, 2021 (%)
Global Sickle Cell Disease Drug Market Segment Percentages, by Application, 2021 (%)
Global Sickle Cell Disease Drug Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Sickle Cell Disease Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sickle Cell Disease Drug revenues share in global market, 2021 (%)
Key companies Sickle Cell Disease Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Sickle Cell Disease Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Sickle Cell Disease Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sickle Cell Disease Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Sickle Cell Disease Drug companies in 2021 (%)
The global Sickle Cell Disease Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ARQ-092 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sickle Cell Disease Drug include Acceleron Pharma Inc, Addmedica SAS, Angiocrine Bioscience Inc, Annexin Pharmaceuticals AB, ArQule Inc, Bio Products Laboratory Ltd, Bioverativ Inc, bluebird bio Inc and Bristol-Myers Squibb Co, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sickle Cell Disease Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sickle Cell Disease Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sickle Cell Disease Drug Market Segment Percentages, by Type, 2021 (%)
- ARQ-092
- BIVV-003
- CAL-H
- CTX-001
- DRX-194
- Others
Global Sickle Cell Disease Drug Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinic
- Others
Global Sickle Cell Disease Drug Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Sickle Cell Disease Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sickle Cell Disease Drug revenues share in global market, 2021 (%)
Key companies Sickle Cell Disease Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Sickle Cell Disease Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Acceleron Pharma Inc
- Addmedica SAS
- Angiocrine Bioscience Inc
- Annexin Pharmaceuticals AB
- ArQule Inc
- Bio Products Laboratory Ltd
- Bioverativ Inc
- bluebird bio Inc
- Bristol-Myers Squibb Co
- Calimmune Inc
- CRISPR Therapeutics
- CSL Ltd
- Daiichi Sankyo Co Ltd
- Editas Medicine Inc
- Errant Gene Therapeutics LLC
- Gamida Cell Ltd
- Genethon SA
- Gilead Sciences Inc
- Global Blood Therapeutics Inc
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Sickle Cell Disease Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sickle Cell Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SICKLE CELL DISEASE DRUG OVERALL MARKET SIZE
2.1 Global Sickle Cell Disease Drug Market Size: 2021 VS 2028
2.2 Global Sickle Cell Disease Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Sickle Cell Disease Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Sickle Cell Disease Drug Players in Global Market
3.2 Top Global Sickle Cell Disease Drug Companies Ranked by Revenue
3.3 Global Sickle Cell Disease Drug Revenue by Companies
3.4 Global Sickle Cell Disease Drug Sales by Companies
3.5 Global Sickle Cell Disease Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Sickle Cell Disease Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Sickle Cell Disease Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sickle Cell Disease Drug Players in Global Market
3.8.1 List of Global Tier 1 Sickle Cell Disease Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Sickle Cell Disease Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Sickle Cell Disease Drug Market Size Markets, 2021 & 2028
4.1.2 ARQ-092
4.1.3 BIVV-003
4.1.4 CAL-H
4.1.5 CTX-001
4.1.6 DRX-194
4.1.7 Others
4.2 By Type - Global Sickle Cell Disease Drug Revenue & Forecasts
4.2.1 By Type - Global Sickle Cell Disease Drug Revenue, 2017-2022
4.2.2 By Type - Global Sickle Cell Disease Drug Revenue, 2023-2028
4.2.3 By Type - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Sickle Cell Disease Drug Sales & Forecasts
4.3.1 By Type - Global Sickle Cell Disease Drug Sales, 2017-2022
4.3.2 By Type - Global Sickle Cell Disease Drug Sales, 2023-2028
4.3.3 By Type - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
4.4 By Type - Global Sickle Cell Disease Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Sickle Cell Disease Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Sickle Cell Disease Drug Revenue & Forecasts
5.2.1 By Application - Global Sickle Cell Disease Drug Revenue, 2017-2022
5.2.2 By Application - Global Sickle Cell Disease Drug Revenue, 2023-2028
5.2.3 By Application - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Sickle Cell Disease Drug Sales & Forecasts
5.3.1 By Application - Global Sickle Cell Disease Drug Sales, 2017-2022
5.3.2 By Application - Global Sickle Cell Disease Drug Sales, 2023-2028
5.3.3 By Application - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
5.4 By Application - Global Sickle Cell Disease Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Sickle Cell Disease Drug Market Size, 2021 & 2028
6.2 By Region - Global Sickle Cell Disease Drug Revenue & Forecasts
6.2.1 By Region - Global Sickle Cell Disease Drug Revenue, 2017-2022
6.2.2 By Region - Global Sickle Cell Disease Drug Revenue, 2023-2028
6.2.3 By Region - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Sickle Cell Disease Drug Sales & Forecasts
6.3.1 By Region - Global Sickle Cell Disease Drug Sales, 2017-2022
6.3.2 By Region - Global Sickle Cell Disease Drug Sales, 2023-2028
6.3.3 By Region - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Sickle Cell Disease Drug Revenue, 2017-2028
6.4.2 By Country - North America Sickle Cell Disease Drug Sales, 2017-2028
6.4.3 US Sickle Cell Disease Drug Market Size, 2017-2028
6.4.4 Canada Sickle Cell Disease Drug Market Size, 2017-2028
6.4.5 Mexico Sickle Cell Disease Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Sickle Cell Disease Drug Revenue, 2017-2028
6.5.2 By Country - Europe Sickle Cell Disease Drug Sales, 2017-2028
6.5.3 Germany Sickle Cell Disease Drug Market Size, 2017-2028
6.5.4 France Sickle Cell Disease Drug Market Size, 2017-2028
6.5.5 U.K. Sickle Cell Disease Drug Market Size, 2017-2028
6.5.6 Italy Sickle Cell Disease Drug Market Size, 2017-2028
6.5.7 Russia Sickle Cell Disease Drug Market Size, 2017-2028
6.5.8 Nordic Countries Sickle Cell Disease Drug Market Size, 2017-2028
6.5.9 Benelux Sickle Cell Disease Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Sickle Cell Disease Drug Revenue, 2017-2028
6.6.2 By Region - Asia Sickle Cell Disease Drug Sales, 2017-2028
6.6.3 China Sickle Cell Disease Drug Market Size, 2017-2028
6.6.4 Japan Sickle Cell Disease Drug Market Size, 2017-2028
6.6.5 South Korea Sickle Cell Disease Drug Market Size, 2017-2028
6.6.6 Southeast Asia Sickle Cell Disease Drug Market Size, 2017-2028
6.6.7 India Sickle Cell Disease Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Sickle Cell Disease Drug Revenue, 2017-2028
6.7.2 By Country - South America Sickle Cell Disease Drug Sales, 2017-2028
6.7.3 Brazil Sickle Cell Disease Drug Market Size, 2017-2028
6.7.4 Argentina Sickle Cell Disease Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sickle Cell Disease Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Sickle Cell Disease Drug Sales, 2017-2028
6.8.3 Turkey Sickle Cell Disease Drug Market Size, 2017-2028
6.8.4 Israel Sickle Cell Disease Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Sickle Cell Disease Drug Market Size, 2017-2028
6.8.6 UAE Sickle Cell Disease Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Acceleron Pharma Inc
7.1.1 Acceleron Pharma Inc Corporate Summary
7.1.2 Acceleron Pharma Inc Business Overview
7.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Major Product Offerings
7.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.1.5 Acceleron Pharma Inc Key News
7.2 Addmedica SAS
7.2.1 Addmedica SAS Corporate Summary
7.2.2 Addmedica SAS Business Overview
7.2.3 Addmedica SAS Sickle Cell Disease Drug Major Product Offerings
7.2.4 Addmedica SAS Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.2.5 Addmedica SAS Key News
7.3 Angiocrine Bioscience Inc
7.3.1 Angiocrine Bioscience Inc Corporate Summary
7.3.2 Angiocrine Bioscience Inc Business Overview
7.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Major Product Offerings
7.3.4 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.3.5 Angiocrine Bioscience Inc Key News
7.4 Annexin Pharmaceuticals AB
7.4.1 Annexin Pharmaceuticals AB Corporate Summary
7.4.2 Annexin Pharmaceuticals AB Business Overview
7.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Major Product Offerings
7.4.4 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.4.5 Annexin Pharmaceuticals AB Key News
7.5 ArQule Inc
7.5.1 ArQule Inc Corporate Summary
7.5.2 ArQule Inc Business Overview
7.5.3 ArQule Inc Sickle Cell Disease Drug Major Product Offerings
7.5.4 ArQule Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.5.5 ArQule Inc Key News
7.6 Bio Products Laboratory Ltd
7.6.1 Bio Products Laboratory Ltd Corporate Summary
7.6.2 Bio Products Laboratory Ltd Business Overview
7.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Major Product Offerings
7.6.4 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.6.5 Bio Products Laboratory Ltd Key News
7.7 Bioverativ Inc
7.7.1 Bioverativ Inc Corporate Summary
7.7.2 Bioverativ Inc Business Overview
7.7.3 Bioverativ Inc Sickle Cell Disease Drug Major Product Offerings
7.7.4 Bioverativ Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.7.5 Bioverativ Inc Key News
7.8 bluebird bio Inc
7.8.1 bluebird bio Inc Corporate Summary
7.8.2 bluebird bio Inc Business Overview
7.8.3 bluebird bio Inc Sickle Cell Disease Drug Major Product Offerings
7.8.4 bluebird bio Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.8.5 bluebird bio Inc Key News
7.9 Bristol-Myers Squibb Co
7.9.1 Bristol-Myers Squibb Co Corporate Summary
7.9.2 Bristol-Myers Squibb Co Business Overview
7.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Major Product Offerings
7.9.4 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.9.5 Bristol-Myers Squibb Co Key News
7.10 Calimmune Inc
7.10.1 Calimmune Inc Corporate Summary
7.10.2 Calimmune Inc Business Overview
7.10.3 Calimmune Inc Sickle Cell Disease Drug Major Product Offerings
7.10.4 Calimmune Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.10.5 Calimmune Inc Key News
7.11 CRISPR Therapeutics
7.11.1 CRISPR Therapeutics Corporate Summary
7.11.2 CRISPR Therapeutics Sickle Cell Disease Drug Business Overview
7.11.3 CRISPR Therapeutics Sickle Cell Disease Drug Major Product Offerings
7.11.4 CRISPR Therapeutics Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.11.5 CRISPR Therapeutics Key News
7.12 CSL Ltd
7.12.1 CSL Ltd Corporate Summary
7.12.2 CSL Ltd Sickle Cell Disease Drug Business Overview
7.12.3 CSL Ltd Sickle Cell Disease Drug Major Product Offerings
7.12.4 CSL Ltd Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.12.5 CSL Ltd Key News
7.13 Daiichi Sankyo Co Ltd
7.13.1 Daiichi Sankyo Co Ltd Corporate Summary
7.13.2 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Business Overview
7.13.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Major Product Offerings
7.13.4 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.13.5 Daiichi Sankyo Co Ltd Key News
7.14 Editas Medicine Inc
7.14.1 Editas Medicine Inc Corporate Summary
7.14.2 Editas Medicine Inc Business Overview
7.14.3 Editas Medicine Inc Sickle Cell Disease Drug Major Product Offerings
7.14.4 Editas Medicine Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.14.5 Editas Medicine Inc Key News
7.15 Errant Gene Therapeutics LLC
7.15.1 Errant Gene Therapeutics LLC Corporate Summary
7.15.2 Errant Gene Therapeutics LLC Business Overview
7.15.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Major Product Offerings
7.15.4 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.15.5 Errant Gene Therapeutics LLC Key News
7.16 Gamida Cell Ltd
7.16.1 Gamida Cell Ltd Corporate Summary
7.16.2 Gamida Cell Ltd Business Overview
7.16.3 Gamida Cell Ltd Sickle Cell Disease Drug Major Product Offerings
7.16.4 Gamida Cell Ltd Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.16.5 Gamida Cell Ltd Key News
7.17 Genethon SA
7.17.1 Genethon SA Corporate Summary
7.17.2 Genethon SA Business Overview
7.17.3 Genethon SA Sickle Cell Disease Drug Major Product Offerings
7.17.4 Genethon SA Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.17.5 Genethon SA Key News
7.18 Gilead Sciences Inc
7.18.1 Gilead Sciences Inc Corporate Summary
7.18.2 Gilead Sciences Inc Business Overview
7.18.3 Gilead Sciences Inc Sickle Cell Disease Drug Major Product Offerings
7.18.4 Gilead Sciences Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.18.5 Gilead Sciences Inc Key News
7.19 Global Blood Therapeutics Inc
7.19.1 Global Blood Therapeutics Inc Corporate Summary
7.19.2 Global Blood Therapeutics Inc Business Overview
7.19.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Major Product Offerings
7.19.4 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.19.5 Global Blood Therapeutics Inc Key News
8 GLOBAL SICKLE CELL DISEASE DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global Sickle Cell Disease Drug Production Capacity, 2017-2028
8.2 Sickle Cell Disease Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Sickle Cell Disease Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SICKLE CELL DISEASE DRUG SUPPLY CHAIN ANALYSIS
10.1 Sickle Cell Disease Drug Industry Value Chain
10.2 Sickle Cell Disease Drug Upstream Market
10.3 Sickle Cell Disease Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sickle Cell Disease Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Sickle Cell Disease Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sickle Cell Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SICKLE CELL DISEASE DRUG OVERALL MARKET SIZE
2.1 Global Sickle Cell Disease Drug Market Size: 2021 VS 2028
2.2 Global Sickle Cell Disease Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Sickle Cell Disease Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Sickle Cell Disease Drug Players in Global Market
3.2 Top Global Sickle Cell Disease Drug Companies Ranked by Revenue
3.3 Global Sickle Cell Disease Drug Revenue by Companies
3.4 Global Sickle Cell Disease Drug Sales by Companies
3.5 Global Sickle Cell Disease Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Sickle Cell Disease Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Sickle Cell Disease Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sickle Cell Disease Drug Players in Global Market
3.8.1 List of Global Tier 1 Sickle Cell Disease Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Sickle Cell Disease Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Sickle Cell Disease Drug Market Size Markets, 2021 & 2028
4.1.2 ARQ-092
4.1.3 BIVV-003
4.1.4 CAL-H
4.1.5 CTX-001
4.1.6 DRX-194
4.1.7 Others
4.2 By Type - Global Sickle Cell Disease Drug Revenue & Forecasts
4.2.1 By Type - Global Sickle Cell Disease Drug Revenue, 2017-2022
4.2.2 By Type - Global Sickle Cell Disease Drug Revenue, 2023-2028
4.2.3 By Type - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Sickle Cell Disease Drug Sales & Forecasts
4.3.1 By Type - Global Sickle Cell Disease Drug Sales, 2017-2022
4.3.2 By Type - Global Sickle Cell Disease Drug Sales, 2023-2028
4.3.3 By Type - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
4.4 By Type - Global Sickle Cell Disease Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Sickle Cell Disease Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Sickle Cell Disease Drug Revenue & Forecasts
5.2.1 By Application - Global Sickle Cell Disease Drug Revenue, 2017-2022
5.2.2 By Application - Global Sickle Cell Disease Drug Revenue, 2023-2028
5.2.3 By Application - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Sickle Cell Disease Drug Sales & Forecasts
5.3.1 By Application - Global Sickle Cell Disease Drug Sales, 2017-2022
5.3.2 By Application - Global Sickle Cell Disease Drug Sales, 2023-2028
5.3.3 By Application - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
5.4 By Application - Global Sickle Cell Disease Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Sickle Cell Disease Drug Market Size, 2021 & 2028
6.2 By Region - Global Sickle Cell Disease Drug Revenue & Forecasts
6.2.1 By Region - Global Sickle Cell Disease Drug Revenue, 2017-2022
6.2.2 By Region - Global Sickle Cell Disease Drug Revenue, 2023-2028
6.2.3 By Region - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Sickle Cell Disease Drug Sales & Forecasts
6.3.1 By Region - Global Sickle Cell Disease Drug Sales, 2017-2022
6.3.2 By Region - Global Sickle Cell Disease Drug Sales, 2023-2028
6.3.3 By Region - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Sickle Cell Disease Drug Revenue, 2017-2028
6.4.2 By Country - North America Sickle Cell Disease Drug Sales, 2017-2028
6.4.3 US Sickle Cell Disease Drug Market Size, 2017-2028
6.4.4 Canada Sickle Cell Disease Drug Market Size, 2017-2028
6.4.5 Mexico Sickle Cell Disease Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Sickle Cell Disease Drug Revenue, 2017-2028
6.5.2 By Country - Europe Sickle Cell Disease Drug Sales, 2017-2028
6.5.3 Germany Sickle Cell Disease Drug Market Size, 2017-2028
6.5.4 France Sickle Cell Disease Drug Market Size, 2017-2028
6.5.5 U.K. Sickle Cell Disease Drug Market Size, 2017-2028
6.5.6 Italy Sickle Cell Disease Drug Market Size, 2017-2028
6.5.7 Russia Sickle Cell Disease Drug Market Size, 2017-2028
6.5.8 Nordic Countries Sickle Cell Disease Drug Market Size, 2017-2028
6.5.9 Benelux Sickle Cell Disease Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Sickle Cell Disease Drug Revenue, 2017-2028
6.6.2 By Region - Asia Sickle Cell Disease Drug Sales, 2017-2028
6.6.3 China Sickle Cell Disease Drug Market Size, 2017-2028
6.6.4 Japan Sickle Cell Disease Drug Market Size, 2017-2028
6.6.5 South Korea Sickle Cell Disease Drug Market Size, 2017-2028
6.6.6 Southeast Asia Sickle Cell Disease Drug Market Size, 2017-2028
6.6.7 India Sickle Cell Disease Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Sickle Cell Disease Drug Revenue, 2017-2028
6.7.2 By Country - South America Sickle Cell Disease Drug Sales, 2017-2028
6.7.3 Brazil Sickle Cell Disease Drug Market Size, 2017-2028
6.7.4 Argentina Sickle Cell Disease Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sickle Cell Disease Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Sickle Cell Disease Drug Sales, 2017-2028
6.8.3 Turkey Sickle Cell Disease Drug Market Size, 2017-2028
6.8.4 Israel Sickle Cell Disease Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Sickle Cell Disease Drug Market Size, 2017-2028
6.8.6 UAE Sickle Cell Disease Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Acceleron Pharma Inc
7.1.1 Acceleron Pharma Inc Corporate Summary
7.1.2 Acceleron Pharma Inc Business Overview
7.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Major Product Offerings
7.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.1.5 Acceleron Pharma Inc Key News
7.2 Addmedica SAS
7.2.1 Addmedica SAS Corporate Summary
7.2.2 Addmedica SAS Business Overview
7.2.3 Addmedica SAS Sickle Cell Disease Drug Major Product Offerings
7.2.4 Addmedica SAS Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.2.5 Addmedica SAS Key News
7.3 Angiocrine Bioscience Inc
7.3.1 Angiocrine Bioscience Inc Corporate Summary
7.3.2 Angiocrine Bioscience Inc Business Overview
7.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Major Product Offerings
7.3.4 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.3.5 Angiocrine Bioscience Inc Key News
7.4 Annexin Pharmaceuticals AB
7.4.1 Annexin Pharmaceuticals AB Corporate Summary
7.4.2 Annexin Pharmaceuticals AB Business Overview
7.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Major Product Offerings
7.4.4 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.4.5 Annexin Pharmaceuticals AB Key News
7.5 ArQule Inc
7.5.1 ArQule Inc Corporate Summary
7.5.2 ArQule Inc Business Overview
7.5.3 ArQule Inc Sickle Cell Disease Drug Major Product Offerings
7.5.4 ArQule Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.5.5 ArQule Inc Key News
7.6 Bio Products Laboratory Ltd
7.6.1 Bio Products Laboratory Ltd Corporate Summary
7.6.2 Bio Products Laboratory Ltd Business Overview
7.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Major Product Offerings
7.6.4 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.6.5 Bio Products Laboratory Ltd Key News
7.7 Bioverativ Inc
7.7.1 Bioverativ Inc Corporate Summary
7.7.2 Bioverativ Inc Business Overview
7.7.3 Bioverativ Inc Sickle Cell Disease Drug Major Product Offerings
7.7.4 Bioverativ Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.7.5 Bioverativ Inc Key News
7.8 bluebird bio Inc
7.8.1 bluebird bio Inc Corporate Summary
7.8.2 bluebird bio Inc Business Overview
7.8.3 bluebird bio Inc Sickle Cell Disease Drug Major Product Offerings
7.8.4 bluebird bio Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.8.5 bluebird bio Inc Key News
7.9 Bristol-Myers Squibb Co
7.9.1 Bristol-Myers Squibb Co Corporate Summary
7.9.2 Bristol-Myers Squibb Co Business Overview
7.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Major Product Offerings
7.9.4 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.9.5 Bristol-Myers Squibb Co Key News
7.10 Calimmune Inc
7.10.1 Calimmune Inc Corporate Summary
7.10.2 Calimmune Inc Business Overview
7.10.3 Calimmune Inc Sickle Cell Disease Drug Major Product Offerings
7.10.4 Calimmune Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.10.5 Calimmune Inc Key News
7.11 CRISPR Therapeutics
7.11.1 CRISPR Therapeutics Corporate Summary
7.11.2 CRISPR Therapeutics Sickle Cell Disease Drug Business Overview
7.11.3 CRISPR Therapeutics Sickle Cell Disease Drug Major Product Offerings
7.11.4 CRISPR Therapeutics Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.11.5 CRISPR Therapeutics Key News
7.12 CSL Ltd
7.12.1 CSL Ltd Corporate Summary
7.12.2 CSL Ltd Sickle Cell Disease Drug Business Overview
7.12.3 CSL Ltd Sickle Cell Disease Drug Major Product Offerings
7.12.4 CSL Ltd Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.12.5 CSL Ltd Key News
7.13 Daiichi Sankyo Co Ltd
7.13.1 Daiichi Sankyo Co Ltd Corporate Summary
7.13.2 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Business Overview
7.13.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Major Product Offerings
7.13.4 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.13.5 Daiichi Sankyo Co Ltd Key News
7.14 Editas Medicine Inc
7.14.1 Editas Medicine Inc Corporate Summary
7.14.2 Editas Medicine Inc Business Overview
7.14.3 Editas Medicine Inc Sickle Cell Disease Drug Major Product Offerings
7.14.4 Editas Medicine Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.14.5 Editas Medicine Inc Key News
7.15 Errant Gene Therapeutics LLC
7.15.1 Errant Gene Therapeutics LLC Corporate Summary
7.15.2 Errant Gene Therapeutics LLC Business Overview
7.15.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Major Product Offerings
7.15.4 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.15.5 Errant Gene Therapeutics LLC Key News
7.16 Gamida Cell Ltd
7.16.1 Gamida Cell Ltd Corporate Summary
7.16.2 Gamida Cell Ltd Business Overview
7.16.3 Gamida Cell Ltd Sickle Cell Disease Drug Major Product Offerings
7.16.4 Gamida Cell Ltd Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.16.5 Gamida Cell Ltd Key News
7.17 Genethon SA
7.17.1 Genethon SA Corporate Summary
7.17.2 Genethon SA Business Overview
7.17.3 Genethon SA Sickle Cell Disease Drug Major Product Offerings
7.17.4 Genethon SA Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.17.5 Genethon SA Key News
7.18 Gilead Sciences Inc
7.18.1 Gilead Sciences Inc Corporate Summary
7.18.2 Gilead Sciences Inc Business Overview
7.18.3 Gilead Sciences Inc Sickle Cell Disease Drug Major Product Offerings
7.18.4 Gilead Sciences Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.18.5 Gilead Sciences Inc Key News
7.19 Global Blood Therapeutics Inc
7.19.1 Global Blood Therapeutics Inc Corporate Summary
7.19.2 Global Blood Therapeutics Inc Business Overview
7.19.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Major Product Offerings
7.19.4 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales and Revenue in Global (2017-2022)
7.19.5 Global Blood Therapeutics Inc Key News
8 GLOBAL SICKLE CELL DISEASE DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global Sickle Cell Disease Drug Production Capacity, 2017-2028
8.2 Sickle Cell Disease Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Sickle Cell Disease Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SICKLE CELL DISEASE DRUG SUPPLY CHAIN ANALYSIS
10.1 Sickle Cell Disease Drug Industry Value Chain
10.2 Sickle Cell Disease Drug Upstream Market
10.3 Sickle Cell Disease Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sickle Cell Disease Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Sickle Cell Disease Drug in Global Market
Table 2. Top Sickle Cell Disease Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Sickle Cell Disease Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Sickle Cell Disease Drug Revenue Share by Companies, 2017-2022
Table 5. Global Sickle Cell Disease Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Sickle Cell Disease Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Sickle Cell Disease Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Sickle Cell Disease Drug Product Type
Table 9. List of Global Tier 1 Sickle Cell Disease Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sickle Cell Disease Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sickle Cell Disease Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Sickle Cell Disease Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Sickle Cell Disease Drug Sales (K Pcs), 2023-2028
Table 16. By Application – Global Sickle Cell Disease Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Sickle Cell Disease Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Sickle Cell Disease Drug Sales (K Pcs), 2023-2028
Table 21. By Region – Global Sickle Cell Disease Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Sickle Cell Disease Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Sickle Cell Disease Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Sickle Cell Disease Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Sickle Cell Disease Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Sickle Cell Disease Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Sickle Cell Disease Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Sickle Cell Disease Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Sickle Cell Disease Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Sickle Cell Disease Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Sickle Cell Disease Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Sickle Cell Disease Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Sickle Cell Disease Drug Sales, (K Pcs), 2023-2028
Table 46. Acceleron Pharma Inc Corporate Summary
Table 47. Acceleron Pharma Inc Sickle Cell Disease Drug Product Offerings
Table 48. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Addmedica SAS Corporate Summary
Table 50. Addmedica SAS Sickle Cell Disease Drug Product Offerings
Table 51. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Angiocrine Bioscience Inc Corporate Summary
Table 53. Angiocrine Bioscience Inc Sickle Cell Disease Drug Product Offerings
Table 54. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Annexin Pharmaceuticals AB Corporate Summary
Table 56. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product Offerings
Table 57. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. ArQule Inc Corporate Summary
Table 59. ArQule Inc Sickle Cell Disease Drug Product Offerings
Table 60. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Bio Products Laboratory Ltd Corporate Summary
Table 62. Bio Products Laboratory Ltd Sickle Cell Disease Drug Product Offerings
Table 63. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Bioverativ Inc Corporate Summary
Table 65. Bioverativ Inc Sickle Cell Disease Drug Product Offerings
Table 66. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. bluebird bio Inc Corporate Summary
Table 68. bluebird bio Inc Sickle Cell Disease Drug Product Offerings
Table 69. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Bristol-Myers Squibb Co Corporate Summary
Table 71. Bristol-Myers Squibb Co Sickle Cell Disease Drug Product Offerings
Table 72. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Calimmune Inc Corporate Summary
Table 74. Calimmune Inc Sickle Cell Disease Drug Product Offerings
Table 75. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. CRISPR Therapeutics Corporate Summary
Table 77. CRISPR Therapeutics Sickle Cell Disease Drug Product Offerings
Table 78. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. CSL Ltd Corporate Summary
Table 80. CSL Ltd Sickle Cell Disease Drug Product Offerings
Table 81. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Daiichi Sankyo Co Ltd Corporate Summary
Table 83. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product Offerings
Table 84. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Editas Medicine Inc Corporate Summary
Table 86. Editas Medicine Inc Sickle Cell Disease Drug Product Offerings
Table 87. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Errant Gene Therapeutics LLC Corporate Summary
Table 89. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product Offerings
Table 90. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Gamida Cell Ltd Corporate Summary
Table 92. Gamida Cell Ltd Sickle Cell Disease Drug Product Offerings
Table 93. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Genethon SA Corporate Summary
Table 95. Genethon SA Sickle Cell Disease Drug Product Offerings
Table 96. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. Gilead Sciences Inc Corporate Summary
Table 98. Gilead Sciences Inc Sickle Cell Disease Drug Product Offerings
Table 99. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Global Blood Therapeutics Inc Corporate Summary
Table 101. Global Blood Therapeutics Inc Sickle Cell Disease Drug Product Offerings
Table 102. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 103. Sickle Cell Disease Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 104. Global Sickle Cell Disease Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Sickle Cell Disease Drug Production by Region, 2017-2022 (K Pcs)
Table 106. Global Sickle Cell Disease Drug Production by Region, 2023-2028 (K Pcs)
Table 107. Sickle Cell Disease Drug Market Opportunities & Trends in Global Market
Table 108. Sickle Cell Disease Drug Market Drivers in Global Market
Table 109. Sickle Cell Disease Drug Market Restraints in Global Market
Table 110. Sickle Cell Disease Drug Raw Materials
Table 111. Sickle Cell Disease Drug Raw Materials Suppliers in Global Market
Table 112. Typical Sickle Cell Disease Drug Downstream
Table 113. Sickle Cell Disease Drug Downstream Clients in Global Market
Table 114. Sickle Cell Disease Drug Distributors and Sales Agents in Global Market
Table 1. Key Players of Sickle Cell Disease Drug in Global Market
Table 2. Top Sickle Cell Disease Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Sickle Cell Disease Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Sickle Cell Disease Drug Revenue Share by Companies, 2017-2022
Table 5. Global Sickle Cell Disease Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Sickle Cell Disease Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Sickle Cell Disease Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Sickle Cell Disease Drug Product Type
Table 9. List of Global Tier 1 Sickle Cell Disease Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sickle Cell Disease Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sickle Cell Disease Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Sickle Cell Disease Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Sickle Cell Disease Drug Sales (K Pcs), 2023-2028
Table 16. By Application – Global Sickle Cell Disease Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Sickle Cell Disease Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Sickle Cell Disease Drug Sales (K Pcs), 2023-2028
Table 21. By Region – Global Sickle Cell Disease Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Sickle Cell Disease Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Sickle Cell Disease Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Sickle Cell Disease Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Sickle Cell Disease Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Sickle Cell Disease Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Sickle Cell Disease Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Sickle Cell Disease Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Sickle Cell Disease Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Sickle Cell Disease Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Sickle Cell Disease Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Sickle Cell Disease Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Sickle Cell Disease Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Sickle Cell Disease Drug Sales, (K Pcs), 2023-2028
Table 46. Acceleron Pharma Inc Corporate Summary
Table 47. Acceleron Pharma Inc Sickle Cell Disease Drug Product Offerings
Table 48. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Addmedica SAS Corporate Summary
Table 50. Addmedica SAS Sickle Cell Disease Drug Product Offerings
Table 51. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Angiocrine Bioscience Inc Corporate Summary
Table 53. Angiocrine Bioscience Inc Sickle Cell Disease Drug Product Offerings
Table 54. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Annexin Pharmaceuticals AB Corporate Summary
Table 56. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product Offerings
Table 57. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. ArQule Inc Corporate Summary
Table 59. ArQule Inc Sickle Cell Disease Drug Product Offerings
Table 60. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Bio Products Laboratory Ltd Corporate Summary
Table 62. Bio Products Laboratory Ltd Sickle Cell Disease Drug Product Offerings
Table 63. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Bioverativ Inc Corporate Summary
Table 65. Bioverativ Inc Sickle Cell Disease Drug Product Offerings
Table 66. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. bluebird bio Inc Corporate Summary
Table 68. bluebird bio Inc Sickle Cell Disease Drug Product Offerings
Table 69. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Bristol-Myers Squibb Co Corporate Summary
Table 71. Bristol-Myers Squibb Co Sickle Cell Disease Drug Product Offerings
Table 72. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Calimmune Inc Corporate Summary
Table 74. Calimmune Inc Sickle Cell Disease Drug Product Offerings
Table 75. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. CRISPR Therapeutics Corporate Summary
Table 77. CRISPR Therapeutics Sickle Cell Disease Drug Product Offerings
Table 78. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. CSL Ltd Corporate Summary
Table 80. CSL Ltd Sickle Cell Disease Drug Product Offerings
Table 81. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Daiichi Sankyo Co Ltd Corporate Summary
Table 83. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product Offerings
Table 84. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Editas Medicine Inc Corporate Summary
Table 86. Editas Medicine Inc Sickle Cell Disease Drug Product Offerings
Table 87. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Errant Gene Therapeutics LLC Corporate Summary
Table 89. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product Offerings
Table 90. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Gamida Cell Ltd Corporate Summary
Table 92. Gamida Cell Ltd Sickle Cell Disease Drug Product Offerings
Table 93. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Genethon SA Corporate Summary
Table 95. Genethon SA Sickle Cell Disease Drug Product Offerings
Table 96. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. Gilead Sciences Inc Corporate Summary
Table 98. Gilead Sciences Inc Sickle Cell Disease Drug Product Offerings
Table 99. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Global Blood Therapeutics Inc Corporate Summary
Table 101. Global Blood Therapeutics Inc Sickle Cell Disease Drug Product Offerings
Table 102. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 103. Sickle Cell Disease Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 104. Global Sickle Cell Disease Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Sickle Cell Disease Drug Production by Region, 2017-2022 (K Pcs)
Table 106. Global Sickle Cell Disease Drug Production by Region, 2023-2028 (K Pcs)
Table 107. Sickle Cell Disease Drug Market Opportunities & Trends in Global Market
Table 108. Sickle Cell Disease Drug Market Drivers in Global Market
Table 109. Sickle Cell Disease Drug Market Restraints in Global Market
Table 110. Sickle Cell Disease Drug Raw Materials
Table 111. Sickle Cell Disease Drug Raw Materials Suppliers in Global Market
Table 112. Typical Sickle Cell Disease Drug Downstream
Table 113. Sickle Cell Disease Drug Downstream Clients in Global Market
Table 114. Sickle Cell Disease Drug Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Sickle Cell Disease Drug Segment by Type
Figure 2. Sickle Cell Disease Drug Segment by Application
Figure 3. Global Sickle Cell Disease Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sickle Cell Disease Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sickle Cell Disease Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Sickle Cell Disease Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Sickle Cell Disease Drug Revenue in 2021
Figure 9. By Type - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Sickle Cell Disease Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Sickle Cell Disease Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 19. US Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 24. Germany Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 33. China Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 40. Brazil Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 44. Turkey Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Sickle Cell Disease Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Sickle Cell Disease Drug by Region, 2021 VS 2028
Figure 50. Sickle Cell Disease Drug Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Sickle Cell Disease Drug Segment by Type
Figure 2. Sickle Cell Disease Drug Segment by Application
Figure 3. Global Sickle Cell Disease Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sickle Cell Disease Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sickle Cell Disease Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Sickle Cell Disease Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Sickle Cell Disease Drug Revenue in 2021
Figure 9. By Type - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Sickle Cell Disease Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Sickle Cell Disease Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 19. US Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 24. Germany Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 33. China Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 40. Brazil Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Sickle Cell Disease Drug Sales Market Share, 2017-2028
Figure 44. Turkey Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Sickle Cell Disease Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Sickle Cell Disease Drug by Region, 2021 VS 2028
Figure 50. Sickle Cell Disease Drug Industry Value Chain
Figure 51. Marketing Channels
